Actively Recruiting
Large-scale Multi-omics Analysis of Cerebrospinal Fluid
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2024-10-10
150
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to explore the role of cerebrospinal fluid (CSF) biomarkers in aging and neurodegenerative diseases.
CONDITIONS
Official Title
Large-scale Multi-omics Analysis of Cerebrospinal Fluid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 0 to 90 years
- Patients admitted for surgery under spinal anesthesia due to non-neurological conditions, such as lower limb fractures or hemorrhoids
- Pediatric patients undergoing surgical treatment for tethered spinal cord syndrome
You will not qualify if you...
- Patients with neurological conditions, including encephalitis, Parkinson's disease, Alzheimer's disease, hydrocephalus, brain tumors, and psychiatric disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310058
Actively Recruiting
Research Team
J
Junming Zhu, MD. phD
CONTACT
W
Wei Gao
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here